Search research articles
Contact Us
Filters
Showing results (311-320 of 749) with videos related to
Page
of 75
Sort By:
Seminars in Thrombosis and Hemostasis
|
May 20, 2009
Coagulopathies and thrombosis: usual and unusual causes and associations, part I
Massimo Franchini, Giuseppe Lippi, Emmanuel J Favaloro
Seminars in Thrombosis and Hemostasis
|
December 27, 2011
Holiday thrombosis
Giuseppe Lippi, Massimo Franchini, Emmanuel J Favaloro
Expert Opinion on Biological Therapy
|
March 21, 2012
Biological therapies for von Willebrand disease
Emmanuel J Favaloro, Massimo Franchini, Giuseppe Lippi
Seminars in Thrombosis and Hemostasis
|
May 9, 2025
Thrombotic Complications in Hemophilia: An Intricate Conundrum
Massimo Franchini, Daniele Focosi, Pier Mannuccio Mannucci
Seminars in Thrombosis and Hemostasis
|
February 9, 2024
Tranexamic Acid: An Evergreen Hemostatic Agent
Massimo Franchini, Daniele Focosi, Pier Mannuccio Mannucci
Expert Review of Anti-Infective Therapy
|
February 26, 2025
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges
Daniele Focosi, David J Sullivan, Massimo Franchini
Haematologica
|
January 26, 2023
How we manage cardiovascular disease in patients with hemophilia
Massimo Franchini, Daniele Focosi, Pier Mannuccio Mannucci
Therapeutic Advances in Hematology
|
January 6, 2022
Prophylactic management of patients with von Willebrand disease
Massimo Franchini, Omid Seidizadeh, Pier Mannuccio Mannucci
European Journal of Haematology
|
May 14, 2021
COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome
Massimo Franchini, Giancarlo Maria Liumbruno, Mario Pezzo
Thrombosis and Haemostasis
|
August 9, 2006
Inhibitors in mild/moderate haemophilia A: an update
Massimo Franchini, Gian Luca Salvagno, Giuseppe Lippi
Page
of 75
Search research articles
Search
Showing results (311-320 of 749) with videos related to
Sort By:
Page
of 75
Seminars in Thrombosis and Hemostasis
|
May 20, 2009
Coagulopathies and thrombosis: usual and unusual causes and associations, part I
Massimo Franchini, Giuseppe Lippi, Emmanuel J Favaloro
Seminars in Thrombosis and Hemostasis
|
December 27, 2011
Holiday thrombosis
Giuseppe Lippi, Massimo Franchini, Emmanuel J Favaloro
Expert Opinion on Biological Therapy
|
March 21, 2012
Biological therapies for von Willebrand disease
Emmanuel J Favaloro, Massimo Franchini, Giuseppe Lippi
Seminars in Thrombosis and Hemostasis
|
May 9, 2025
Thrombotic Complications in Hemophilia: An Intricate Conundrum
Massimo Franchini, Daniele Focosi, Pier Mannuccio Mannucci
Seminars in Thrombosis and Hemostasis
|
February 9, 2024
Tranexamic Acid: An Evergreen Hemostatic Agent
Massimo Franchini, Daniele Focosi, Pier Mannuccio Mannucci
Expert Review of Anti-Infective Therapy
|
February 26, 2025
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges
Daniele Focosi, David J Sullivan, Massimo Franchini
Haematologica
|
January 26, 2023
How we manage cardiovascular disease in patients with hemophilia
Massimo Franchini, Daniele Focosi, Pier Mannuccio Mannucci
Therapeutic Advances in Hematology
|
January 6, 2022
Prophylactic management of patients with von Willebrand disease
Massimo Franchini, Omid Seidizadeh, Pier Mannuccio Mannucci
European Journal of Haematology
|
May 14, 2021
COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome
Massimo Franchini, Giancarlo Maria Liumbruno, Mario Pezzo
Thrombosis and Haemostasis
|
August 9, 2006
Inhibitors in mild/moderate haemophilia A: an update
Massimo Franchini, Gian Luca Salvagno, Giuseppe Lippi
Page
of 75